| Style | Citing Format |
|---|---|
| MLA | Shaygannejad V, Mirmosayyeb O, Yazdan Panah M. "Diabetes Mellitus and Multiple Sclerosis: Methodological Considerations in Evidence Synthesis." Multiple Sclerosis and Related Disorders, vol. 114, no. , 2026, pp. -. |
| APA | Shaygannejad V, Mirmosayyeb O, Yazdan Panah M (2026). Diabetes Mellitus and Multiple Sclerosis: Methodological Considerations in Evidence Synthesis. Multiple Sclerosis and Related Disorders, 114(), -. |
| Chicago | Shaygannejad V, Mirmosayyeb O, Yazdan Panah M. "Diabetes Mellitus and Multiple Sclerosis: Methodological Considerations in Evidence Synthesis." Multiple Sclerosis and Related Disorders 114, no. (2026): -. |
| Harvard | Shaygannejad V, Mirmosayyeb O, Yazdan Panah M (2026) 'Diabetes Mellitus and Multiple Sclerosis: Methodological Considerations in Evidence Synthesis', Multiple Sclerosis and Related Disorders, 114(), pp. -. |
| Vancouver | Shaygannejad V, Mirmosayyeb O, Yazdan Panah M. Diabetes Mellitus and Multiple Sclerosis: Methodological Considerations in Evidence Synthesis. Multiple Sclerosis and Related Disorders. 2026;114():-. |
| BibTex | @article{ author = {Shaygannejad V and Mirmosayyeb O and Yazdan Panah M}, title = {Diabetes Mellitus and Multiple Sclerosis: Methodological Considerations in Evidence Synthesis}, journal = {Multiple Sclerosis and Related Disorders}, volume = {114}, number = {}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Shaygannejad V AU - Mirmosayyeb O AU - Yazdan Panah M TI - Diabetes Mellitus and Multiple Sclerosis: Methodological Considerations in Evidence Synthesis JO - Multiple Sclerosis and Related Disorders VL - 114 IS - SP - EP - PY - 2026 ER - |